Press Releases by "Otsuka Pharmaceutical Co., Ltd."

• Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
  [ Pharmaceuticals | 2012-11-20]
• Official Sponsor of Osaka Marathon for Second Consecutive Year Otsuka Pharmaceutical Will Continue to Support Safe Running and Encourage Runners to Complete the Full Distance
  [ Pharmaceuticals | 2012-11-20]
• Otsuka Pharmaceutical and Abdi İbrahim Established a Joint Venture Company for Pharmaceutical Sales in Turkey
  [ Pharmaceuticals | 2012-11-06]
• Otsuka Pharmaceutical Tokushima Itano Factory to Cosponsor Asan Walking Festival in Itano A Portion of Entry Fees to be Donated to Great East Japan Earthquake Relief Efforts
  [ Pharmaceuticals | 2012-11-05]
• Otsuka’s Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
  [ Pharmaceuticals | 2012-11-05]
• Kenja no Shokutaku Double Support Food for Specified Health Use with Dual Function Suppressing the Absorption of Both Sugars and Lipids, to Launch in Japan for the First Time
  [ Pharmaceuticals | 2012-10-29]
• Super Vitamin D, Containing the Daily Optimum Dose of Vitamin D in One Single Tablet Launched from Nature Made® - America’s Number One Dietary Supplement Brand
  [ Pharmaceuticals | 2012-10-01]
• New “Poppy Seed ＆ Lemon” from Gerblé to launch on October 15 The No.1 French Health Food Brand now in 3,000 stores nationwide
  [ Pharmaceuticals | 2012-09-24]
• Kyowa Hakko Kirin Returns to Otsuka Pharmaceutical the Rights to Develop and Market Busulfex®, for Use As a Part of Conditioning Regimen Prior to Hematopoietic Progenitor Cell Transplantation, in Japan and in Asian Countries ＆ Regions
  [ Pharmaceuticals | 2012-09-14]
• ABILIFY® ,The First Antipsychotic Agent in Japan Applying for Adjunctive Treatment in Major Depressive Disorder
  [ Pharmaceuticals | 2012-09-03]
• Otsuka, the First Pharmaceutical Company in Japan to Have Been Certified for “ISO22301”, the International Standard for Business Continuity Management
  [ Pharmaceuticals | 2012-08-29]
• Vasopressin V2-Receptor Antagonist, Samsca® Tablets were filed Additional Indication of the Treatment of Fluid Retention Associated with Cirrhosis of the Liver
  [ Pharmaceuticals | 2012-08-01]
• Pocari Sweat Launches in Vietnam through New Joint Venture Company. Vietnam Launch is the17th Market in the World Where the Pocari Sweat is Sold
  [ Pharmaceuticals | 2012-08-01]
• Proteus Digital Health, Inc. and Otsuka Pharmaceutical Co., Ltd. Announce Worldwide Agreement to Develop Novel Digital Health Products
  [ Pharmaceuticals | 2012-07-06]
• Otsuka Pharmaceutical × Nakacho, Tokushima Prefecture Largest Free Live Music Concert in Japan to Be Held
  [ Pharmaceuticals | 2012-06-30]
• Otsuka Pharmaceutical and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
  [ Pharmaceuticals | 2012-06-29]
• Reverse Daylight Savings Program to Shift Peak Energy Consumption
  [ Pharmaceuticals | 2012-06-26]
• UCB Japan Files for Indication of Pediatric Epilepsy (Partial Onset Seizures) for E Keppra® Tablet; New Dry Syrup Formulation Filed at the Same Time
  [ Pharmaceuticals | 2012-06-21]
• Acucela and Otsuka Pharmaceutical Announce the Initiation of a Phase 3 Clinical Trial to Evaluate Rebamipide Ophthalmic Suspension in Patients with Dry Eye Syndrome
  [ Pharmaceuticals | 2012-06-19]
• Otsuka Pharmaceutical To Boost Production Capacity and Increase Sales with Third Pocari Sweat Plant in Guandong Province,China
  [ Pharmaceuticals | 2012-06-19]

Most Popular: "Otsuka Pharmaceutical Co., Ltd."